Avanos Medical (AVNS) Competitors

Avanos Medical (NYSE:AVNS) and Axonics (NASDAQ:AXNX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

Do analysts prefer AVNS or AXNX?

Axonics has a consensus target price of $71.00, suggesting a potential upside of 0.03%. Given Axonics' higher probable upside, analysts clearly believe Axonics is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Axonics	0 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the MarketBeat Community believe in AVNS or AXNX?

Axonics received 88 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 66.41% of users gave Axonics an outperform vote while only 55.84% of users gave Avanos Medical an outperform vote.

Company	Underperform	Outperform
Avanos Medical	Outperform Votes 86 55.84%	Underperform Votes 68 44.16%
Axonics	Outperform Votes 174 66.41%	Underperform Votes 88 33.59%

Is AVNS or AXNX more profitable?

Avanos Medical has a net margin of 2.30% compared to Axonics' net margin of -1.31%. Avanos Medical's return on equity of 4.70% beat Axonics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	2.30%	4.70%	3.46%
Axonics	-1.31%	0.36%	0.31%

Which has preferable earnings & valuation, AVNS or AXNX?

Axonics has lower revenue, but higher earnings than Avanos Medical. Axonics is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$673.30M	1.28	-$61.80M	$0.34	54.94
Axonics	$366.38M	9.90	-$6.09M	-$0.12	-591.45

Do institutionals & insiders believe in AVNS or AXNX?

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 99.5% of Axonics shares are owned by institutional investors. 2.9% of Avanos Medical shares are owned by company insiders. Comparatively, 1.9% of Axonics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media refer more to AVNS or AXNX?

In the previous week, Axonics had 2 more articles in the media than Avanos Medical. MarketBeat recorded 7 mentions for Axonics and 5 mentions for Avanos Medical. Axonics' average media sentiment score of 0.78 beat Avanos Medical's score of 0.55 indicating that Axonics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Axonics	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, AVNS or AXNX?

Avanos Medical has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Axonics has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500.

Summary

Avanos Medical and Axonics tied by winning 8 of the 16 factors compared between the two stocks.